FcγRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell FCγRIIIa, independently of the FCγRIIIa-48L/R/H phenotype

Blood

Volumn 90, Issue 3, 1997, Pages 1109-1114

  Koene, Harry R ^b   Kleijer, Marion ^b   Algra, Johan ^b   Roos, Dirk ^b   Von Dem Borne, Albert E G Kr ^b   De Haas, Masja ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; STRUCTURE ACTIVITY RELATION; ALLELE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; IMMUNOLOGY; METABOLISM; PHENOTYPE; PROTEIN BINDING;

ALLELES; ANTIBODIES, MONOCLONAL; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN BINDING; RECEPTORS, IGG;

EID: 0030611643     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.1109     Document Type: Article

References (25)

1. De Haas M, Vossebeld PJM, Von dem Borne AEGKr, Roos D: Fcγ receptors of phagocytes. J Lab Clin Med 126:330, 1995
2. Bredius RGM, Fijen CAP, De Haas M, Kuijper EJ, Weening RS, Van de Winkel JGJ, Out TA: Role of neutrophil FcγRII (CD32) and FcγRIIIb (CD 16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology 83:624, 1994
3. Salmon JE, Edberg JC, Kimberly RP: Fcγ receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest 85:1287, 1990
4. Salmon JE, Edberg JC, Brogle NL, Kimberly RP: Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 89:1274, 1992
5. Salmon JE, Millard SS, Brogle NL, Kimberly RP: Fcγ receptor IIIb enhances Fcγ receptor IIa function in an oxidant dependent and allele-sensitive manner. J Clin Invest 95:2877, 1995
6. Parren PWHI, Warmerdam PAM, Boeije LCM, Arts J, Westerwaal NAC, Vlug A, Capel PJA, Aarden LA, Van de Winkel JGJ: On the interaction of IgG subclasses with the low-affinity FcγRIIa (CD32) on human monocytes, neutrophils and platelets. J Clin Invest 90:1537, 1992
7. Sanders LAM, Van de Winkel JGJ, Rijkers GT, Voorhorst-Ogink MM, De Haas M, Capel PJA, Zegers BJM: Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 170:854, 1994
8. Bredius RGM, Derkx BHF, Fijen CAP, De Wit TPM, De Haas M, Weening RS, Van de Winkel JGJ, Out TA: Fcγ Receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170:848, 1994
9. Burgess JK, Lindeman R, Chesterman CN, Chong BH: Single amino acid mutation of Fc receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 91:761, 1995
10. Wilson ME, Kalmar JR: FcγRIIa (CD32): A potential marker defining susceptibility to localized juvenile periodontitis. J Periodontol 67:323, 1996
11. Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, Capel PJA, Westerdaal NAC, Spierenburg GT, Gmelig-Meyling FHJ, Van de Winkel JGJ: Skewed distribution of IgG Fc recptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 39:1832, 1995
12. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, Ramsey-Goldman R, Peterson MGE, Kimberly RP: FcγRIIA alleles are heritable risk factors for Lupus nephritis in African-Americans. J Clin Invest 97:1348, 1996
13. Ravetch JV, Perussia B: Alternative membrane forms of FcγRIII (CD16) on human NK cells and neutrophils: Cell-type specitic expression of two genes which differ in single nucleotide substitutions. J Exp Med 170:481, 1989
14. Hibbs ML, Tolvanen M, Carpen O: Membrane-proximal Iglike domain of FcγRIII (CD16) contains residues critical for ligand binding. J Immunol 152:4466, 1994
15. Tamm A, Kister A, Nolte KU, Gessner JE, Schmidt RE: The IgG binding site of human FcγRIIIB receptor involves CC' and FG loops of the membrane-proximal domain. J Biol Chem 271:3659, 1996
16. Perussia B, Starr S, Abraham S, Fanning V, Trinchieri G: Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol 130:2133, 1983
17. De Haas M, Koene HR, Kleijer M, De Vries E, Simsek S, Van Tol MJD, Roos D, Von dem Borne AEGKr: A triallelic Fcγ receptor type IIIA polymorphism influences the binding of human IgG by NK cell FcRIIIa. J Immunol 156:2948, 1996
18. De Vries E, Koene HR, Vossen JM, Gratama JW, Von dem Borne AEGKr, Waaijer JLM, Haraldsson A, De Haas M, Van Tol MJD: Identification of an unusual Fcγ receptor IIIa on natural killer cells in a patient with recurrent infections. Blood 88:3022, 1996
19. Tamm A, Schmidt RE: The binding epitopes of human CD16 (FcγRIII) monoclonal antibodies. Implications for ligand binding. J lmmunol 157:1576, 1996
20. Vance BA, Huizinga TWJ, Wardwell K, Guyre PM: Binding of monomeric human IgG defines an expression polymorphism of FcγRIII on large granular lymphocyte/natural killer cells. J lmmunol 151:6429, 1993
21. Hulett MD, Hogarth PM: Molecular basis of Fc receptor function. Adv lmmunol 57:1, 1994
22. Miller KL, Duchemin A, Anderson CL: A novel role for the Fc receptor gamma subunit: Enhancement of FcγR ligand affinity. J Exp Med 183:2227, 1996
23. Jawahar S, Moody C, Chan M,. Finberg R, Geha R, Chatila T: Natural killer (NK) cell deficiency associated with an epitopedeficient Fcγ receptor type IIIA (CD16-II). Clin Exp lmmunol 103:408, 1996
24. Sulica A. Gherman M, Galatiuc C, Manciulea M, Herberman RB: Inhibition of human natural killer cell activity by cytophilic immunoglobulin G. J lmmunol 128:1031, 1982
25. Gherman M, Manciulea M, Bancu AC, Sulica A, Stanworth DR, Herberman RB: Regulation of human natural cytotoxicity by IgG. Characterization of the structural site on monomeric IgG responsible for inhibiting natural killer cell activity. Mol lmmunol 24:743, 1987